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Abstract The goal of the present study was to define the role of
gelatinase A in angiogenesis. We performed corneal micropocket
assays in gelatinase A-deficient mice and their age-matched wild-
type littermates. The corneal neovascular area in gelatinase A-
deficient mice (0.15 þ 0.14 mm2) was significantly less than that
of wild-type littermates (0.53 þ 0.35 mm2 ; P6 0.01). Similarly,
aortic ring assays showed significant reduction of endothelial
outgrowth in gelatinase A-deficient mice (0.26 þ 0.14 mm2) as
compared to wild-type littermates (0.44 þ 0.06 mm2 ; P6 0.05).
These results suggest that gelatinase A may play an important
role in the regulation of corneal angiogenesis. ß 2001 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
Angiogenesis, the formation of new vessels from existing
vessels, is a complex process, which involves the degradation
of the vascular basement membrane and migration and pro-
liferation of vascular endothelial cells. Extracellular matrix
(ECM) proteolysis is now being appreciated as an important
biochemical and cellular regulator of neovascularization, vas-
cular morphogenesis and vascular invasion [1,2]. At the initial
stages of angiogenesis, the pre-existing basement membrane is
digested by endothelial enzymes such as matrix metalloprotei-
nases (MMPs), allowing these cells to traverse the basement
membrane. Thus, the regulation of angiogenesis may be de-
pendent on the proper temporal and spatial expression of
these enzymes within the vascular microenvironment.
MMPs are a family of zinc-containing, ECM-degrading en-
zymes that share common structural and functional proper-
ties. Since both gelatinase A (MMP-2) and gelatinase B
(MMP-9) possess the ability to cleave type IV collagen, which
is a major component of the basement membrane, these
MMPs have been suggested to play a crucial role not only
in wound healing [3,4,5] but also in angiogenesis [1,6,7].
In the present study, we aimed to de¢ne the physiological
role of gelatinase A in the process of angiogenesis. We exam-
ined corneal angiogenesis induced by basic ¢broblast growth
factor (bFGF) in mice de¢cient in gelatinase A in vivo, to
determine whether a null mutation in the gelatinase A gene
leads to the suppression of angiogenetic response. Addition-
ally, we prepared aortic rings from gelatinase A-de¢cient mice
to determine the role of gelatinase A in vascular endothelial
cell migration and tube formation in vitro.
2. Materials and methods
2.1. Animals
All animal studies were conducted in accordance with the Animal
Care and Use Committee guidelines of the Massachusetts Eye and
Ear In¢rmary and the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research. Gelatinase A-de¢cient mice and
age- and strain-matched wild-type littermates 6^10 weeks of age
were used. The generation of gelatinase A-de¢cient mice has recently
been described in detail [6]. Heterozygous littermates were mated to
obtain homozygous animals. Genotyping of animals was performed
by polymerase chain reaction (PCR) of DNA obtained from tail bi-
opsies. Primers for wild-type alleles were located in 5P region (5P-TCC
ACC CGG TGC TGC CAG CAC TCT TCC AGC CCA GC-3P) and
exon 1 (5P-GCC GGG GAA CTT GAT GAT GG-3P), and primers
for mutated alleles were located in PGK-neo cassette (5P-CTT GGG
TGG AGA GGC TAT TC-3P and 5P-AGG TGA GAT GAC AGG
AGA TC-3P).
2.2. Corneal micropocket assay
A mouse corneal micropocket assay was carried out as previously
described [8,9]. The mice were anesthetized by a combined ketamine
and xylazine injection. Lidocaine eye drops were used for local anes-
thesia. Corneal micropockets were created with a modi¢ed von Graefe
knife in gelatinase A-de¢cient mice (n = 15) and wild-type littermates
(n = 20). Hydron pellets (0.4U0.4 mm) containing 50 ng of human
bFGF (RpD Systems, Minneapolis, MN, USA) and 40 Wg of sucrose
aluminum sulfate were implanted into corneal pockets. O£oxacin eye
drops were instilled after surgery. The eyes were examined and photo-
graphed on the seventh postoperative day by slit lamp microscopy
(Nikon, Tokyo, Japan). Color images were magni¢ed 100U to allow
precise measurement of corneal neovascularization. The neovascular
area was calculated using Area (mm2) = 0.2UZUmaximal vessel
length (mm)Uclock hours of neovascularization as described previ-
ously [10].
2.3. Light microscopic analysis
Mouse eyes, obtained on day 7 after bFGF pellet implantation,
were ¢xed in 4% paraformaldehyde and embedded in para⁄n. 3-
Wm-thick sections were cut and stained with hematoxylin and eosin.
The sections were viewed and photographed with a Nikon Eclipse
E800 microscope.
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2.4. Confocal laser scanning microscope
Wild-type mouse corneas, obtained on day 7 after bFGF pellet
implantation, were frozen in OCT compound (Baxter Scienti¢c, Co-
lumbia, MD, USA). Cryostat sections, 7 Wm thick, were ¢xed in
acetone for 10 min. After treatment with 1% bovine serum albumin,
the sections were incubated for 1 h with rabbit anti-gelatinase A anti-
body (Oncogene, Manhasset, NY, USA), rat anti-CD31 antibody
(Pharmingen, San Diego, CA, USA), and goat anti-type IV collagen
antibody (Southern Biotechnology, Birmingham, AL, USA). Second-
ary antibodies used were £uorescein isothiocyanate (FITC)-conju-
gated anti-rabbit IgG antibody (Jackson Immunoresearch Laborato-
ries, West Grove, PA, USA), Cy5-conjugated anti-rat IgG antibody
(Jackson Immunoresearch Laboratories) and rhodamine-conjugated
anti-goat IgG antibody (Jackson Immunoresearch Laboratories).
The sections were viewed with a Leica TCS 4D confocal laser scan-
ning microscope (Leica, Heidelberg, Germany). Cy5 labelling origi-
nally generates a red £uorescent signal, which is depicted as blue for
image analysis; this allows distinction between CD31 and the rhod-
amine-labelled collagen type IV.
2.5. Aortic ring assay
Aortic ring assays were performed as described by Nicosia et al.
[11]. Brie£y, aortas were obtained from gelatinase A-de¢cient mice or
wild-type mice. Fatty tissues around the aorta were carefully removed
under a surgical microscope. 1-mm-long aortic rings were cut and
rinsed in ¢ve consecutive washes of Medium 199 (Life Technologies,
Rockville, MD, USA). 48-well plates were coated with 150 Wl of
Matrigel (B.D., Bedford, MA, USA). After gelling at 37‡C for 30
min, aortic ring was placed on its side on top of the gel and sealed
in place with an overlay of 100 Wl of Matrigel. After gelling at 37‡C
for 1 h, 300 Wl of culture medium (Medium 199, Life Technologies)
containing 5 ng/ml of bFGF (RpD Systems) with or without fetal calf
serum (FCS) were added to each well. On day 7, the gels were photo-
graphed with a phase contrast microscope equipped with a digital
Spot camera (Micro Video Instruments, Avon, MA, USA). The
area of endothelial outgrowth was analyzed by manually encircling
and computing square pixels by NIH image 1.62 software (NIH,
Bethesda, MD, USA). The endothelial nature of the outgrowth was
con¢rmed by immunostaining with CD31 antibody. Data are pre-
sented as mean þ S.E.M. Statistical signi¢cance was evaluated by us-
ing unpaired t-test. Di¡erences were considered signi¢cant at P6 0.05.
3. Results
Homozygosity of gelatinase A-de¢cient mice used in our
experiments was con¢rmed by genotyping of tail tip DNA
using PCR (Fig. 1). Interbreeding of heterozygous mice gave
rise to the expected Mendelian distribution of homozygous
mutant mice (3/3), heterozygous (+/3) mice, and wild-type
(+/+) mice.
3.1. Diminished bFGF response in corneas of gelatinase
A-de¢cient mice
To determine whether corneal vascularization was altered in
gelatinase A-null mice, micropellets of the slow release poly-
mer-hydron containing bFGF were implanted into the cornea
of gelatinase A-null mice and their wild-type littermates. The
implanted corneas were photographed on day 7 after implan-
tation (Fig. 2A and B). By day 7, 17/20 wild-type mice had
visible corneal neovascularization extending more than 0.1
mm from the limbus, as compared to 4/15 in the gelatinase
A-de¢cient group. The total area of neovascularization was
Fig. 1. PCR analysis of genomic DNA. The PCR fragments corre-
sponding to normal alleles (450 bp) and targeted alleles (280 bp) are
shown. +/+, wild-type; +/3, heterozygous; 3/3, homozygous mu-
tant.
Fig. 2. Corneal neovascularization induced by bFGF. Pellets con-
taining 50 ng of bFGF were implanted into corneas of wild-type lit-
termates (A) and gelatinase A-de¢cient mice (B) and corneas were
photographed with slit lamp microscope on day 7 after implanta-
tion. Hematoxylin and eosin staining of cornea from wild-type (C)
and gelatinase A-de¢cient mouse (D) (magni¢cation U50). Corneal
neovascularization was quantitated on day 7 after pellet implanta-
tion. Data represent mean values ( þ S.E.M.). *P6 0.01 (E).
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calculated. The induced neovascular area was 0.53 þ 0.35 mm2
in wild-type littermates and 0.15 þ 0.14 mm2 in gelatinase A-
de¢cient mice. The di¡erences between these two groups were
statistically signi¢cant (P6 0.01) (Fig. 2E).
Hematoxylin and eosin staining con¢rmed the presence of
newly formed vessels in the mid-stroma in both wild-type and
gelatinase A-de¢cient mice; the vessels were more prominent
in the wild-type mice. No stromal edema and minimal in£am-
matory response were observed (Fig. 2C and D).
Triple staining confocal laser scanning microscopy in cor-
neal new vessels enabled the simultaneous detection and local-
ization of gelatinase A, CD31 and type IV collagen as shown
in Fig. 3. The anti-CD31 antibody was used as a speci¢c
marker of the vascular endothelial cells. Expression of gelat-
inase A was represented by green (Fig. 3A), CD31 by blue
(Fig. 3B), and type IV collagen by red (Fig. 3C). The confocal
images suggested that gelatinase A was localized to the vas-
cular endothelial region of corneal new vessels surrounded by
type IV collagen in wild-type mice (Fig. 3D and E).
3.2. Reduced in vitro migratory activity of aortic endothelial
cells of gelatinase-de¢cient mice
Decreased corneal neovascularization in gelatinase A-null
mice and the positive staining of gelatinase A in wild-type
vascular endothelial cells prompted us to explore whether
the absence of gelatinase A a¡ects endothelial cell migration
in Matrigel. To examine this in vitro, an aortic ring assay was
carried out. In the presence of 10% FCS, the di¡erence be-
tween the area of endothelial sprouting in both groups was
not signi¢cant (data not shown). However, endothelial out-
growth area in gelatinase A-null mice (0.26 þ 0.14 mm2) was
much less than that formed in wild-type littermates
(0.44 þ 0.06 mm2) after stimulation with 5 ng/ml bFGF (Fig.
4).
4. Discussion
Although it has become apparent that MMPs may play a
role in the process of angiogenesis [1], little information is
available concerning the in vivo mechanisms by which speci¢c
MMPs, such as gelatinase A (MMP-2), contribute to this pro-
cess. In this report, we demonstrated that the angiogenetic
response induced by bFGF is markedly reduced in mice lack-
ing a functional gelatinase A gene compared with that of wild-
type animals. Our data con¢rm the results reported by Elkin
et al. [12] who showed that halofuginone, an inhibitor of
collagen K1(I) and gelatinase A gene expression, almost com-
pletely suppressed bFGF-induced angiogenesis in vivo and
inhibited endothelial capillary tube formation in vitro.
The use of MMP-de¢cient mice is potentially more advan-
tageous because the distinct activities of the particular MMP
would be eliminated. In addition, non-speci¢c inhibition of
ECM components and of other MMPs are minimized. Our
data using gelatinase A-de¢cient mice provide more striking
evidence for a critical role of this enzyme in angiogenesis.
The results of our study support the ¢ndings of Itoh et al.
[6] studying tumor implantation in gelatinase A-de¢cient mice.
They analyzed tumor growth and vascularization in the gelat-
Fig. 3. Confocal micrographs of corneal neovascularization in wild-type mice (A^E) and gelatinase A-de¢cient mice (F). Immunohistochemical
localization of gelatinase A (green) (A), CD31 (blue) (B), type IV collagen (red) (C), and triple staining (D) in wild-type mice. Triple staining
confocal image demonstrates gelatinase A localization to the vascular endothelial region (D). Longitudinal section of corneal vessel con¢rming
intraluminal localization of gelatinase A (green) as compared to surrounding localization of type IV collagen (red) in wild-type mice (E). Triple
staining in gelatinase A-de¢cient mice (F). Bar: 10 Wm.
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inase A-null host by using a dorsal air sac method and ob-
served that tumor-induced angiogenesis in these animals was
partially suppressed.
The precise mechanism by which gelatinase A in£uences
angiogenesis is not clear. Our data from confocal microscopic
examination strongly suggest that gelatinase A expression in
vascular endothelial cells may play an important role during
corneal neovascularization. To better understand how gelati-
nase A de¢ciency may lead to suppression of angiogenetic
response, we conducted the aortic ring assays in Matrigel. A
major component of Matrigel is type IV collagen, which is a
substrate of gelatinase A. Our observations that endothelial
cells from gelatinase A-de¢cient mice fail to display normal
outgrowth in the presence of 5 ng/ml bFGF suggest that the
di¡erences in bFGF-induced angiogenesis between gelatinase
A-de¢cient mice and wild-type may be related to di¡erences in
the vascular endothelial cells. It might be di⁄cult for the
endothelial cells lacking a functional gelatinase A to traverse
the basement membrane. Therefore the degradation of base-
ment membrane by gelatinase A may be an important event in
the process of angiogenesis. However, we cannot exclude the
possibility that gelatinase A may induce endothelial prolifer-
ation. This notion is consistent with previous studies showing
suppressive e¡ects of gelatinase A inhibitors (TIMP-2 and
neutralizing antibodies to gelatinase A) on endothelial prolif-
eration [13].
Zhou et al. [14] performed bFGF micropocket assays and
showed complete absence of corneal angiogenesis in mem-
brane type 1-MMP (MT1-MMP; MMP-14)-de¢cient mice.
MT1-MMP contains a transmembrane domain, which facili-
tates the cell-mediated activation of gelatinase A. Thus, it is
tempting to speculate that activation of gelatinase A by MT1-
MMP is important for the regulation of angiogenesis [14].
Corneal micropocket assay in mice requires a relatively de-
manding technique, but o¡ers a distinct advantage in inves-
tigating angiogenesis. In£ammation, as the major angiogenic
stimulus, can be minimized using this model, and measure-
ments of the neovascular response can be readily and non-
invasively documented with slit lamp biomicroscopy [8].
The gelatinase A-null mice developed almost normally, and
bFGF induced corneal angiogenesis even in the gelatinase A-
mutant mice, clearly indicating that the angiogenetic process
is not totally dependent on gelatinase A. One possibility that
needs further investigation is that other MMPs such as gelat-
inase B (MMP-9) are upregulated in response to the absence
of gelatinase A in the mutant mice. The production of gelat-
inase A 3/3 ; gelatinase B 3/3 double-mutant mice may be
valuable for testing this hypothesis.
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Fig. 4. Photographs of aorta ring assay. Aortic rings from wild-type
littermate (A) and gelatinase A-de¢cient mouse (B) were cultured in
endothelial growth medium containing 5 ng/ml bFGF without FCS.
The di¡erence in the endothelial outgrowth area was observed on
day 7 post-explantation. Bar: 0.2 mm. Quantitation of microvessel
outgrowth from mouse aortic rings (C). Graphs represent mean val-
ues ( þ S.E.M.) of eight samples in each group. *P6 0.05.
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